Tjho-Heslinga R E, Terhaard C H, Schouwenburg P, Hilgers F J, Dolsma W V, Croll G A, Hoogenhout J, Knegt P P, Leer J W, Hordijk G J
Department of Radiotherapy, University Hospital of Leiden, The Netherlands.
Clin Otolaryngol Allied Sci. 1993 Dec;18(6):536-40. doi: 10.1111/j.1365-2273.1993.tb00631.x.
The Dutch Co-operative Head and Neck Oncology Group performed a retrospective, nationwide study of laryngeal cancer between 1975 and 1984. The results for T3 laryngeal cancer treated with primary laryngectomy (n = 137) with post-operative radiotherapy when indicated or planned combined (pre-operative) radiotherapy with laryngectomy (n = 113) are analysed. The disease-free survival independent prognostic factors were treatment modality (planned combined treatment fared better, P = 0.001), incomplete resection of disease (P = 0.006), positive lymph nodes in the neck dissection specimen (P = 0.03) and poor differentiation (P = 0.04). Local control (95% vs. 85%, P = 0.01) as well as regional control (96% vs. 79%, P = 0.0001) was improved in the combined group compared with the primary laryngectomy group. Regional control was 69% for N0 patients if the neck nodes were not treated electively, compared with 98% for the planned combined treatment group. It is concluded that elective treatment of the neck nodes in T3 laryngeal cancer is mandatory. Radiotherapy is preferred, since as well as regional control, local control will also improve.
荷兰头颈肿瘤合作研究组对1975年至1984年间的喉癌进行了一项全国性的回顾性研究。分析了137例接受原发性喉切除术并在必要时进行术后放疗的T3期喉癌患者的结果,以及113例计划进行联合(术前)放疗与喉切除术的患者的结果。无病生存的独立预后因素为治疗方式(计划联合治疗效果更好,P = 0.001)、疾病切除不完全(P = 0.006)、颈部清扫标本中淋巴结阳性(P = 0.03)和分化差(P = 0.04)。与原发性喉切除术组相比,联合治疗组的局部控制率(95%对85%,P = 0.01)和区域控制率(96%对79%,P = 0.0001)均有所提高。如果不对颈部淋巴结进行选择性治疗,N0患者的区域控制率为69%,而计划联合治疗组为98%。结论是,对T3期喉癌的颈部淋巴结进行选择性治疗是必要的。放疗是首选,因为除了区域控制外,局部控制也会得到改善。